Comorbid anxiety predicts lower odds of MDD improvement in a trial of smartphone-delivered interventions
Journal of Affective Disorders · 2026
DOI: 10.1016/j.jad.2025.120416 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2026. Verfasst von Morgan B Talbot und 2 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA, 02139, USA; Harvard Medical School, 25 Shattuck St, Boston, MA, 02115,…. Hauptthemen laut MEDLINE: Anxiety Disorders, Cognitive Behavioral Therapy, Major Depressive Disorder, Mobile Applications. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Comorbid anxiety disorders are common among patients with major depressive disorder (MDD), but their impact on outcomes of digital and smartphone-delivered interventions is not well understood. This study is a secondary analysis of a randomized controlled effectiveness trial (n=638) that assessed three smartphone-delivered interventions: Project EVO (a cognitive training app), iPST (a problem-solving therapy app), and Health Tips (an active control). We applied classical machine learning models (logistic regression, support vector machines, decision trees, random forests, and k-nearest-neighbors) to identify baseline predictors of MDD improvement at 4 weeks after trial enrollment. Our analysis produced a decision tree model indicating that a baseline GAD-7 questionnaire score of 11 or higher, a threshold consistent with at least moderate anxiety, strongly predicts lower odds of MDD improvement in this trial. Our exploratory findings suggest that depressed individuals with comorbid anxiety have reduced odds of substantial improvement in the context of smartphone-delivered interventions, as the association was observed across all three intervention groups. Our work highlights a methodology that can identify interpretable clinical thresholds, which, if validated, could predict symptom trajectories and inform treatment selection and intensity.3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA, 02139, USA; Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA; Boston Children's Hospital, 300 Longwood Avenue, Boston, MA, 021…
- Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA; Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.
- Equ Healthcare, Watertown, MA, 02472, USA.
Förderung
- NIMH NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Institute of Mental Health
- Massachusetts Institute of Technology
- National Science Foundation
Zitieren
APA
Talbot, M. B., Lipschitz, J. M., & Costilla-Reyes, O. (2026). Comorbid anxiety predicts lower odds of MDD improvement in a trial of smartphone-delivered interventions. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.120416
Vancouver
Talbot MB, Lipschitz JM, Costilla-Reyes O. Comorbid anxiety predicts lower odds of MDD improvement in a trial of smartphone-delivered interventions. Journal of Affective Disorders. 2026. doi:10.1016/j.jad.2025.120416
BibTeX
@article{Talbot2026,
author = {Talbot, Morgan B and Lipschitz, Jessica M and Costilla-Reyes, Omar},
title = {Comorbid anxiety predicts lower odds of MDD improvement in a trial of smartphone-delivered interventions},
journal = {Journal of Affective Disorders},
year = {2026},
doi = {10.1016/j.jad.2025.120416}
}
EUVIMED